Randomized trial of hyperfractionation versus conventional fractionation in T2 squamous cell carcinoma of the vocal cord (RTOG 9512)

International Journal of Radiation Oncology Biology Physics

Volumn 89, Issue 5, 2014, Pages 958-963

  Trotti III, Andy ^a   Zhang, Qiang ^b   Bentzen, Søren M ^c   Emami, Bahman ^d   Hammond, M Elizabeth ^e   Jones, Christopher U ^f   Morrison, William H ^g   Sagar, Stephen M ^h   Ridge, John A ⁱ   Fu, Karen K ^j   Ang, K Kian ^g  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b RTOG Statistical Center   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^e LDS HOSPITAL   (United States)

^f Radiological Associates of Sacramento Medical Group Inc   (United States)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ FOX CHASE CANCER CENTER   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ONCOLOGY; RADIOLOGY;

CONVENTIONAL FRACTIONATIONS; CUMULATIVE INCIDENCE; DISEASE-FREE SURVIVAL; FRACTIONATION SCHEDULES; KARNOFSKY PERFORMANCE STATUS; METHODS AND MATERIALS; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA;

HAZARDS;

ADULT; AGED; ARTHROPATHY; ARTICLE; BLOOD TOXICITY; BONE DISEASE; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ESOPHAGUS DISEASE; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; HYPERFRACTIONATION; INTERMETHOD COMPARISON; KARNOFSKY PERFORMANCE STATUS; LARYNX CARCINOMA; LOCAL FAILURE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PHARYNX DISEASE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; SALIVARY GLAND DISEASE; SKIN TOXICITY; SPINAL CORD DISEASE; SQUAMOUS CELL CARCINOMA; STANDARD FRACTIONATION; STOMATITIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIATION INJURIES; VOCAL CORDS;

EID: 84904137058     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2014.04.041     Document Type: Article

References (19)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2012 CA Cancer J Clin 62 2012 10 29
2. W.M. Mendenhall, R.J. Amdur, and C.G. Morris et al. T1-T2N0 squamous cell carcinoma of the glottic larynx treated with radiation therapy J Clin Oncol 19 2001 4029 4036
3. J.C. Horiot, R. Le Fur, and T. N'Guyen et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC Cooperative Group of Radiotherapy Radiother Oncol 25 1992 231 241
4. J.J. Beitler, Q. Zhang, and K.K. Fu et al. Final results of local-regional control and late toxicity of RTOG 90-03: A randomized trial of altered fractionation radiation for locally advanced head and neck cancer Int J Radiat Oncol Biol Phys 89 2014 13 20
5. M. Zelen The randomization and stratification of patients to clinical trials J Chron Dis 27 1974 365 375
6. J.D. Kalbfleisch, and R.L. Prentice The Statistical Analysis of Failure Time Data 1980 John Wiley and Sons New York
7. E.L. Kaplan, and P. Meier Non-parametric estimation from incomplete observations J Am Stat Soc C 53 1958 457 481
8. D.R. Cox Regression models and life-tables (with discussion) J R Stat Soc B 34 1972 178 220
9. J. Bourhis, J. Overgaard, and H. Audry et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis Lancet 368 2006 843 854
10. H. Yamazaki, K. Nishiyama, and E. Tanaka et al. Radiotherapy for early glottic carcinoma (T1N0M0): Results of prospective randomized study of radiation fraction size and overall treatment time Int J Radiat Oncol Biol Phys 64 2006 77 82
11. S.H. Moon, K.H. Cho, and E.J. Chung et al. A prospective randomized trial comparing hypofractionation with conventional fractionation radiotherapy for T1-2 glottic squamous cell carcinomas: Results of a Korean Radiation Oncology Group (KROG-0201) study Radiother Oncol 110 2013 98 103
12. A. Hliniak, B. Gwiazdowska, and Z. Szutkowski et al. A multicentre randomized/controlled trial of a conventional versus modestly accelerated radiotherapy in the laryngeal cancer: Influence of a 1 week shortening overall time Radiother Oncol 62 2002 1 10
13. J. Overgaard, H.S. Hansen, and L. Specht et al. Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial Lancet 362 2003 933 940
14. B.S. Chera, R.J. Amdur, and C.G. Morris et al. T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy Int J Radiat Oncol Biol Phys 78 2010 461 466
15. Q.T. Le, K.K. Fu, and S. Kroll et al. Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma Int J Radiat Oncol Biol Phys 39 1997 115 126
16. A.S. Garden, K. Forster, and P.F. Wong et al. Results of radiotherapy for T2N0 glottic carcinoma: Does the "2" stand for twice-daily treatment? Int J Radiat Oncol Biol Phys 55 2003 322 328
17. M. Canis, A. Martin, and F. Ihler et al. Transoral laser microsurgery in treatment of pt2 and pt3 glottic laryngeal squamous cell carcinoma - results of 391 patients Head Neck 36 2013 859 866
18. K.K. Ang, and L.J. Peters Vocal cord cancer: 2b worse than not 2b? Radiother Oncol 18 1990 365 366
19. E.D. McCoul, and G. Har-El Meta-analysis of impaired vocal cord mobility as a prognostic factor in T2 glottic carcinoma Arch Otolaryngol Head Neck Surg 135 2009 479 486